evalu
perform
laboratorydevelop
multiplex
realtim
revers
transcriptionpcr
assay
ldt
rrtpcr
center
diseas
control
prevent
cdc
rrtpcr
protocol
use
lightcycl
ii
multiplex
xtag
respiratori
viru
panel
xtag
rvp
rapid
immunodiagnost
test
ridt
use
binaxnow
influenza
b
detect
nasopharyng
swab
specimen
pandem
specif
method
test
individu
test
sensit
ridt
confid
interv
ci
ldt
rrtpcr
ci
cdc
rrtpcr
ci
xtag
rvp
ci
neg
ridt
result
use
make
decis
respect
treatment
infect
prevent
rrtpcr
prefer
firstlin
diagnost
test
detect
influenza
spring
novel
influenza
caus
acut
respiratori
ill
identifi
north
america
novel
swineorigin
influenza
viru
investig
team
unit
state
estim
million
infect
hospit
death
caus
viru
midmarch
center
diseas
control
prevent
rapid
laboratori
detect
pandem
must
reli
upon
detect
direct
fluoresc
antigen
test
rapid
antigen
immunodiagnost
test
format
ridt
convent
real
time
reversetranscriptas
polymeras
chain
reaction
rrtpcr
test
storch
pandem
laboratoryconfirm
diagnosi
frequent
obtain
help
earli
initi
antivir
therapi
implement
intervent
infect
prevent
control
first
pandem
influenza
viru
test
mani
molecular
diagnost
advanc
medic
microbiolog
sinc
order
evalu
import
obtain
rrtpcr
firstlin
diagnost
test
detect
studi
np
swab
specimen
ridt
differ
pcrbase
detect
method
includ
laboratorydevelop
rrtpcr
assay
ldt
rrtpcr
center
diseas
control
prevent
cdc
rrtpcr
protocol
xtag
respiratori
viru
panel
luminex
austin
tx
usa
xtag
rvp
may
octob
np
swab
specimen
store
viral
transport
media
xtagrvp
multiplex
rtpcr
system
detect
influenza
influenza
b
rsv
b
parainfluenza
human
metapneumoviru
enterovirusrhinoviru
adenoviru
coronavirus
detect
perform
use
luminex
microfluid
bead
array
platform
follow
manufactur
instruct
interpret
mean
fluoresc
intens
establish
posit
perform
tagit
data
analysi
softwar
tda
util
intern
use
iuo
templat
tda
rvpi
luminex
result
posit
influenza
univers
target
influenza
nonspecif
neg
season
target
consid
posit
inhous
adapt
cdc
protocol
detect
character
influenza
world
health
organ
accomplish
use
format
lightcycl
ii
instrument
roch
indianapoli
usa
primer
probe
reagent
tib
mol
biol
adelphia
nj
usa
reaction
mastermix
setup
cycl
paramet
describ
protocol
amplif
curv
sigmoid
shape
c
valu
observ
swinfa
sw
target
consid
posit
two
rtpcr
assay
detect
influenza
matrix
infa
hemagglutinin
infa
gene
valid
lightcycl
ii
instrument
laboratorydevelop
test
ldt
cdna
synthesi
rna
eluat
ad
volum
master
mix
first
strand
cdna
synthesi
kit
roch
compos
molecular
grade
water
revers
transcriptas
revers
transcriptas
reaction
buffer
rnase
inhibitor
deoxynucleotid
mix
mmoll
random
hexam
primer
cycl
condit
follow
min
min
held
primer
probe
sequenc
reactiv
lambda
bacteriophag
dna
includ
control
inhibit
infa
detect
mastermix
setup
util
faststart
dna
master
kit
roch
includ
per
reaction
follow
molecular
grade
water
mg
mmoll
infa
primerprob
mix
intern
control
lambda
dna
faststart
oligonucleotid
primer
probe
reaction
obtain
premix
follow
concentr
fluaf
taaccgaggtcgaaacgtatgttct
fluar
ggcattttggacaaagcgtcta
cgaaatcgcgcagagacttgaagatgtfl
lambdaf
atgccacgtaagcgaaaca
lambdar
gcataaacgaagcagtcgagt
lambdafl
cacttcccgaataacfl
tib
mol
biol
second
master
mix
infa
target
util
faststart
dna
master
kit
includ
per
reaction
follow
molecular
grade
water
mg
mmoll
infa
primerprob
mix
faststart
oligonucleotid
concentr
infa
reaction
follow
ctcatggtcctacattgtggaaac
tcaaacctttcaaatgatgacactg
agctcctcataatcgatgaatctccfl
tib
mol
biol
assay
aliquot
previous
describ
cdna
product
use
cycl
condit
lightcycl
ii
follow
singl
hold
min
ramp
rate
cycl
ramp
rate
acquisit
mode
singl
ramp
rate
sec
target
step
size
step
delay
cycl
ramp
rate
hold
ramp
rate
infa
infa
target
run
parallel
separ
reaction
plate
detect
nm
infa
mastermix
intern
control
detect
channel
requir
color
compens
file
gener
use
univers
color
compens
kit
tib
mol
biol
cat
amplif
curv
sigmoid
shape
c
valu
observ
infa
infa
target
consid
posit
mean
age
patient
year
mean
age
patient
posit
studi
specimen
test
ldt
rrtpcr
cdc
rrtpcr
xtag
rvp
posit
influenza
specimen
defin
requir
posit
result
obtain
differ
pcrbase
detect
assay
includ
ldt
rrtpcr
xtag
rvp
cdc
rrtpcr
perform
oregon
state
public
health
laboratori
osphl
washington
state
depart
health
wsdoh
cdc
rrtpcr
perform
use
lightcycl
ii
roch
instrument
convers
neg
result
defin
result
pcrbase
detect
assay
neg
singl
posit
result
obtain
rrtpcr
xtag
result
obtain
specimen
ridt
posit
also
posit
singl
pcrbase
method
specimen
confirm
posit
rtpcr
result
posit
neg
method
twelv
consid
neg
one
rtpcr
assay
gave
posit
result
total
np
swab
specimen
subset
confirm
test
osphl
wsdoh
cdc
rrtpcr
similarli
specimen
test
xtag
rvp
influenza
type
result
refer
osphl
wsdoh
laboratori
determin
posit
influenza
cdc
rrtpcr
overal
xtag
rvp
influenza
posit
without
type
report
posit
predict
valu
ppv
tabl
three
hundr
eightysix
np
swab
specimen
test
neg
ridt
test
shown
falseneg
result
increas
sensit
rrtpcr
tabl
demonstr
show
significantli
lower
influenza
viru
rna
target
detect
rrtpcrposit
specimen
ridt
neg
compar
ridt
posit
p
b
interestingli
trueneg
result
contain
anoth
respiratori
viru
coinfect
determin
xtag
rvp
consist
enteroviru
rhinoviru
parainfluenza
human
metapneumoviru
adenoviru
parainfluenza
parainfluenza
influenza
b
influenza
season
influenza
season
april
rrtpcr
swine
flu
panel
assay
cdc
rrtpcr
made
avail
cdc
author
emerg
use
fda
viral
rna
detect
pcr
describ
method
choic
detect
viru
infect
use
rrtpcr
test
permit
highest
sensit
detect
influenza
respiratori
specimen
uniqu
allow
specif
identif
influenza
ridt
wide
adopt
rapid
conveni
requir
less
expertis
perform
consequ
great
deal
attent
place
accuraci
ridt
detect
ridt
previous
demonstr
lower
sensit
rtpcr
detect
season
influenza
often
rang
depend
preval
specimen
type
age
patient
liao
et
al
analyt
sensit
sever
ridt
assay
shown
compar
season
influenza
chan
et
al
clinic
sensit
viru
report
write
committe
consult
clinic
aspect
pandem
influenza
compar
rtpcr
refer
rang
posit
specimen
includ
karr
et
al
velasco
et
al
write
committe
consult
clinic
aspect
pandem
influenza
similar
find
binax
fluab
ridt
studi
sensit
compar
pcr
tabl
low
neg
predict
valu
ridt
influenza
seriou
implic
continu
relianc
ridt
firstlin
diagnost
test
influenza
laboratori
diagnosi
requir
patient
manag
observ
agre
consensu
neg
result
use
make
decis
respect
treatment
infect
prevent
write
committe
consult
clinic
aspect
pandem
influenza
np
swab
sent
laboratori
pandem
test
neg
influenza
shown
contain
respiratori
viru
xtag
rvp
test
find
highlight
import
accur
laboratori
test
support
diagnos
patient
sign
symptom
influenza
xtag
rvp
valuabl
capabl
detect
novel
influenza
viru
strain
util
earli
month
pandem
pcr
could
valid
cdc
rrtpcr
protocol
detect
character
pandem
influenza
specifi
use
format
realtimepcr
instrument
perform
assay
appli
lightcycl
ii
instrument
cdc
inhous
rrtpcr
demonstr
compar
low
sensit
retain
high
ppv
ideal
confirm
test
tabl
protocol
cdc
rrtpcr
assay
distribut
worldwid
world
health
organ
publish
compat
divers
number
differ
instrument
laboratori
need
thoroughli
valid
inhous
perform
limit
studi
molecular
test
perform
retrospect
addit
limit
definit
use
true
posit
wherebi
posit
result
requir
differ
pcrbase
detect
assay
could
penal
individu
assay
superior
perform
bia
would
lead
individu
assay
appear
poorer
specif
detect
influenza
specimen
determin
neg
molecular
assay
summari
pandem
evalu
number
pcrbase
assay
use
group
np
swab
test
ridt
describ
significantli
higher
sensit
rrtpcr
assay
compar
ridt
higher
sensit
rrtpcr
season
pandem
influenza
reduc
use
ridt
diagnosi
treatment
patient
influenzalik
ill
conveni
reli
ridt
firstlin
diagnost
test
come
high
cost
poor
sensit
